USANA Health Sciences, Inc. (NYSE:USNA) Director Sells $21,849.10 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller sold 490 shares of USANA Health Sciences stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $44.59, for a total transaction of $21,849.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

USANA Health Sciences Trading Up 2.9 %

Shares of USANA Health Sciences stock opened at $46.32 on Friday. The company has a fifty day moving average price of $46.38 and a 200 day moving average price of $48.04. USANA Health Sciences, Inc. has a twelve month low of $41.45 and a twelve month high of $69.60. The stock has a market cap of $889.34 million, a price-to-earnings ratio of 14.43, a price-to-earnings-growth ratio of 1.38 and a beta of 0.94.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.35. The company had revenue of $221.08 million for the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. Analysts forecast that USANA Health Sciences, Inc. will post 2.75 earnings per share for the current year.

Hedge Funds Weigh In On USANA Health Sciences

Institutional investors have recently made changes to their positions in the business. Quest Partners LLC bought a new position in USANA Health Sciences during the fourth quarter worth $66,000. CWM LLC lifted its holdings in USANA Health Sciences by 49.6% in the fourth quarter. CWM LLC now owns 1,267 shares of the company’s stock worth $68,000 after acquiring an additional 420 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of USANA Health Sciences by 60.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after purchasing an additional 1,274 shares during the last quarter. Trexquant Investment LP acquired a new stake in shares of USANA Health Sciences during the 4th quarter worth approximately $266,000. Finally, Teacher Retirement System of Texas acquired a new position in USANA Health Sciences during the 3rd quarter valued at approximately $297,000. 54.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

USNA has been the topic of a number of analyst reports. DA Davidson lowered their price objective on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating on the stock in a report on Tuesday. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Friday, January 12th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.